BMC Cancer,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Nov. 28, 2023
Cantharidin
(CTD)
is
the
active
ingredient
of
Chinese
medicine,
which
has
been
traditionally
used
in
multiple
cancers
treatment,
especially
hepatocellular
carcinoma
(HCC).
However,
a
comprehensive
analysis
CTD-related
molecular
mechanism
still
necessary
to
understand
its
functions
HCC
treatment.
This
study
aimed
reveal
novel
targets
and
regulatory
networks
CTD
HCC.A
model
H22
tumour-bearing
mice
was
constructed,
function
tumour
growth
evaluated.
An
integrated
approach
associated
transcriptional
profiling
biological
systems
identify
key
regulators
involved
antitumour
pathways.
The
identified
differential
expression
patterns
were
supported
by
results
Gene
Ontology
(GO)
term
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
enrichment
analyse,
protein-protein
interaction
(PPI)
network
construction.
relationships
between
gene
immunity
evaluated
using
Tumour
Immune
Estimation
Resource
(TIMER).
Prognostic
value
analyzed
with
Kaplan-Meier
plotter.In
present
study,
therapeutic
effect
on
vivo.
We
obtained
profiles,
systematically
intuitively
illustrated
possible
pharmacological
mechanisms
through
signalling
These
revealed
that
differentially
expressed
genes
autophagy,
transcription
factors
(TFs)
related
regulation,
fatty
acid
metabolism
immune
response
HCC.
found
MAPT,
TOP2A,
CENPF
MEFV
hub
autophagy
regulation.
Totally,
14
TFs
have
confirmed
be
critical
for
33
TF
as
mis-regulation
cancer.
cell
infiltration.
In
addition,
downregulated
significantly
enriched
metabolic
regulation
pathways,
after
Furthermore,
miRNAs
these
metabolism-related
constructed
HCC.Taken
together,
our
comprehensively
elucidated
could
act
therapy,
affecting
metabolism.
Our
provide
foundation
mechanistic
clinical
application
treatment
Theranostics,
Journal Year:
2024,
Volume and Issue:
14(5), P. 2099 - 2126
Published: Jan. 1, 2024
Exosomes,
which
are
small
vesicles
enclosed
by
a
lipid
bilayer
and
released
many
cell
types,
widely
dispersed
have
garnered
increased
attention
in
the
field
of
regenerative
medicine
due
to
their
ability
serve
as
indicators
diseases
agents
with
therapeutic
potential.
Exosomes
play
crucial
role
mediating
intercellular
communication
through
transfer
biomolecules,
including
proteins,
lipids,
RNA,
other
molecular
constituents,
between
cells.
The
targeted
transport
proteins
nucleic
acids
specific
cells
has
potential
enhance
or
impair
biological
functions.
applications,
they
can
be
used
alone
combination
approaches.
examination
unique
attributes
functions
these
factors
emerged
prominent
study
realm
biomedical
research.
This
manuscript
summarizes
origins
properties
exosomes,
structural,
biological,
physical,
chemical
aspects.
paper
offers
complete
recent
progress
tissue
repair
medicine,
emphasizing
possible
implications
methods
forthcoming
regeneration
attempts.
Biomarker Research,
Journal Year:
2023,
Volume and Issue:
11(1)
Published: Nov. 19, 2023
Abstract
Tumor-associated
macrophages
(TAMs),
one
of
the
most
abundant
immune
cell
types
in
tumor
microenvironment
(TME),
account
for
approximately
50%
local
hematopoietic
cells.
TAMs
play
an
important
role
tumorigenesis
and
development
through
crosstalk
between
various
cells
cytokines
TME.
Exosomes
are
small
extracellular
vesicles
with
a
diameter
50–150
nm,
that
can
transfer
biological
information
(e.g.,
proteins,
nucleic
acids,
lipids)
from
secretory
to
recipient
circulatory
system,
thereby
influencing
progression
human
diseases,
including
cancer.
Recent
studies
have
suggested
TAMs-derived
exosomes
crucial
roles
malignant
proliferation,
invasion,
metastasis,
angiogenesis,
responses,
drug
resistance,
metabolic
reprogramming.
potential
be
targeted
therapy.
In
addition,
abnormal
expression
non-coding
RNAs
proteins
is
closely
related
clinicopathological
features
patients
cancer,
these
expected
become
new
liquid
biopsy
markers
early
diagnosis,
prognosis,
monitoring
tumors.
this
review,
we
explored
provide
diagnostic
biomarkers
therapeutic
targets
cancer
prevention.
Journal of Cancer,
Journal Year:
2024,
Volume and Issue:
15(13), P. 4219 - 4231
Published: Jan. 1, 2024
Hepatocellular
carcinoma
(HCC),
the
predominant
malignancy
of
digestive
tract,
ranks
as
third
most
common
cause
cancer-related
mortality
globally,
significantly
impeding
human
health
and
lifespan.
Emerging
immunotherapeutic
approaches
have
ignited
fresh
optimism
for
patient
outcomes.
This
investigation
probes
link
between
731
immune
cell
phenotypes
HCC
through
Mendelian
Randomization
single-cell
sequencing,
aiming
to
unearth
viable
drug
targets
dissect
HCC's
etiology.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 21, 2024
In
recent
years,
cancer,
especially
primary
liver
cancer
(including
hepatocellular
carcinoma
and
intrahepatic
cholangiocarcinoma),
has
posed
a
serious
threat
to
human
health.
the
field
of
exosomes
play
an
important
role
in
initiation,
metastasis
interaction
with
tumor
microenvironment.
Exosomes
are
class
nanoscale
extracellular
vesicles
(EVs)secreted
by
most
cells
rich
bioactive
molecules,
including
RNA,
proteins
lipids,
that
mediate
intercellular
communication
during
physiological
pathological
processes.
This
review
reviews
multiple
roles
progression,
as
well
their
effects
on
angiogenesis,
epithelial-mesenchymal
transformation
(EMT),
immune
evasion,
drug
resistance.
have
great
potential
biomarkers
for
diagnosis
prognosis
because
they
carry
specific
molecular
markers
facilitate
early
detection
evaluation
treatment
outcomes.
addition,
exosomes,
new
type
delivery
vector,
unique
advantages
targeted
therapy
provide
strategy
cancer.
The
challenges
prospects
exosome-based
immunotherapy
were
also
discussed.
However,
such
standardization
isolation
techniques
scalability
therapeutic
applications
remain
significant
hurdles.
Cancer Management and Research,
Journal Year:
2025,
Volume and Issue:
Volume 17, P. 23 - 34
Published: Jan. 1, 2025
Background:
Cancer
immunotherapy
is
an
advanced
therapeutic
approach
that
harnesses
the
body's
immune
system
to
target
and
eliminate
tumor
cells.
Traditional
Chinese
medicine
(TCM),
with
a
history
rooted
in
centuries
of
clinical
practice,
plays
crucial
role
enhancing
responses,
alleviating
cancer-related
symptoms,
reducing
risks
infections
complications
cancer
patients.
Methodology:
This
review
systematically
examines
current
literature
on
TCM-based
formulations
immunotherapy.
It
explores
mechanisms
by
which
TCM
augments
particularly
focusing
how
these
influence
both
innate
adaptive
immunity.
Various
herbs
compounds,
their
active
ingredients,
application
prevention
treatment
were
analyzed
through
integrated
preclinical
studies,
trials,
molecular
mechanistic
investigations.
Results:
contribute
therapy
modulating
internal
environment
improve
defense.
They
enhance
system's
ability
detect
destroy
cells,
promote
apoptosis
inhibit
growth
metastasis,
augment
effectiveness
conventional
treatments.
The
highlights
specific
have
demonstrated
significant
anti-cancer
properties,
including
strengthen
responses
provide
synergistic
effects
existing
therapies.
Conclusion:
TCM-derived
represent
promising
addition
anti-tumor
immunity
are
multifaceted,
involving
modulation
cell
activity,
induction,
suppression
progression.
As
evolves,
integration
into
regimens
may
offer
enhanced
efficacy,
reduced
side
effects,
improved
overall
outcomes
for
Further
research
needed
fully
elucidate
potential
safety
immunotherapeutic
strategies
care.
Keywords:
traditional
medicine,
TCM,
cancer,
nanocarriers,
ability,
therapy,
microenvironment,
drug
delivery
systems
Cancer Medicine,
Journal Year:
2025,
Volume and Issue:
14(9)
Published: May 1, 2025
ABSTRACT
Background
Exosomes
are
extracellular
vesicles
ranging
from
40
to
100
nm
in
diameter
that
mediate
intercellular
communication
by
transferring
proteins,
lipids,
nucleic
acids,
and
other
metabolites.
In
the
context
of
cancer,
exosomes
influence
tumor
microenvironment
carrying
regulatory
RNAs
such
as
miRNA,
circRNA,
lncRNA.
They
originate
various
cells,
including
adipocytes,
fibroblasts,
hepatocellular
carcinoma
(HCC)
can
either
promote
or
inhibit
cancer
progression
through
pathways
like
MAPK
PI3K‐Akt.
Aim
This
review
aims
explore
role
solid
cancers,
emphasizing
their
self‐induced
activation
mechanisms
how
they
modulate
behavior.
Methodology
A
comprehensive
recent
literature
was
conducted,
focusing
on
studies
investigated
biological
functions
progression,
molecular
cargo,
cellular
origin,
involvement
signaling
pathways.
Results
Findings
multiple
indicate
cancer‐derived
contribute
proliferation,
metastasis,
therapy
resistance
enhancing
within
microenvironment.
These
activate
oncogenic
serve
biomarkers
therapeutic
targets
due
disease
modulation.
Conclusion
play
a
pivotal
offer
significant
potential
advancing
our
understanding
biology.
Their
capacity
key
facilitate
makes
them
promising
candidates
for
novel
diagnostic
strategies.
Journal of Hepatocellular Carcinoma,
Journal Year:
2024,
Volume and Issue:
Volume 11, P. 525 - 542
Published: March 1, 2024
Purpose:
Transcatheter
arterial
chemoembolization
(TACE)
is
commonly
used
in
the
treatment
of
hepatocellular
carcinoma
(HCC).
However,
not
all
patients
respond
to
this
treatment.
TACE
typically
leads
hypoxia
tumor
microenvironment.
Therefore,
we
aimed
construct
a
prognostic
model
based
on
hypoxia-related
differentially
expressed
microRNA
(miRNAs)
(HCC)
and
investigate
potential
target
mRNAs
for
predicting
response.
Methods:
The
miRNAs
(HRMs)
were
identified
liver
cancer
cells,
then
global
test
was
performed
further
select
which
associated
with
recurrence
vascular
invasion.
A
constructed
multivariate
Cox
regression
analysis;
qRT-PCR
analysis
validate
HCC
cell
lines
under
hypoxic
condition.
We
putative
genes
relationship
between
response,
immune
cells
infiltration.
Results:
established
HRMs
patients,
containing
two
(miR-638,
miR-501-5p),
high-HRMs
score
showed
worse
survival
discovery
validation
cohort;
confirmed
that
these
are
up-regulated
hepatoma
Furthermore,
four
(ADH1B,
CTH,
FTCD,
RCL1),
significantly
score,
immunosuppressive
infiltration,
PDCD1
CTLA4.
Conclusion:
HCC-HRMs
signature
may
be
utilized
as
promising
factor
have
implications
guiding
therapy.
Keywords:
hypoxia,
miRNA,
signature,
carcinoma,
prognosis
Hepatoma Research,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 30, 2023
Hepatocellular
carcinoma
(HCC)
stands
as
one
of
the
most
prevalent
malignant
tumors
globally.
Despite
considerable
advancements
in
HCC
therapies,
therapeutic
resistance
remains
a
significant
challenge
that
compromises
patient
prognosis.
Increasing
evidence
indicates
exosomes,
which
are
secreted
by
cells
tumor
microenvironment
(TME),
pivotal
players
development
HCC.
These
nano-sized
vesicles
mediate
intercellular
communication
TME
through
transfer
bioactive
molecules
such
nucleic
acids,
lipids,
and
proteins.
A
comprehensive
understanding
role
exosomes
could
provide
promising
strategies
for
both
diagnosis
treatment
This
review
mainly
summarizes
involvement
exosomal
cargos
elucidates
their
underlying
mechanisms
to
treatments
HCC,
further
discusses
potential
clinical
applications
diagnostic
biomarkers
targets
overcome
drug